![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action – My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]](https://endoconsult.b-cdn.net/wp-content/uploads/mechanism-of-action-of-incretin-mim.png)
do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action – My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
Maro JC, Platt R, Toh S
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
While GLP-1 medications offer promise in weight management, their role during pregnancy necessitates careful evaluation and consideration
As a result, GLP-1RAs display suppressive effects on mitochondrial functions and oxidative stress on heart failure [79]
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.bmj.com/content/bmj/385/bmj-2023-078483/F1.medium.jpg)
GLP-1RAs act via a multitude of mechanisms in the gut and the pancreas
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.prod.website-files.com/6973b0f39780e0777ead4fbd/69eba404217899320d35d0a2_product%3Dproduct8.webp)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance DPP4 Inhibitor Mechanism of Action My Endo Consult dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eee/12683481/5e5d3d32f437/PDS-34-e70277-g002.jpg)
